Literature DB >> 4040999

Pharmacological alleviation of cholinergic lesion induced memory deficits in rats.

V Haroutunian, P Kanof, K L Davis.   

Abstract

The cholinergic cells of the nucleus basalis of Meynert (nbM) have recently been found to degenerate in Alzheimer's disease and are thought to be at least partly responsible for the cognitive deficits which are characteristic of this disease. These experiments explored the behavioral effects of bilateral excitotoxic lesions of the nbM in adult rats. The first experiment showed that nbM lesions lead to a substantial deficit in the 24 hour retention of the habituation to a novel environment without affecting general exploratory behavior. The second experiment showed that this retention deficit is a general phenomenon reflected in the 72 hour retention of a one trial passive avoidance task. These retention deficits could be reversed by the postacquisition administration of the acetylcholinesterase inhibitor, physostigmine. These results support the hypothesis that central cholinergic systems are involved in the retention of learned responses, and suggest that cholinergic lesion induced retention deficits can be reversed by pharmacological means.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4040999     DOI: 10.1016/0024-3205(85)90531-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  16 in total

Review 1.  Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part II.

Authors:  M Sarter; J Hagan; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I.

Authors:  M Sarter; J Hagan; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 3.  Activating the damaged basal forebrain cholinergic system: tonic stimulation versus signal amplification.

Authors:  M Sarter; J P Bruno; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Cholinergic modulation of memory in rats.

Authors:  V Haroutunian; E Barnes; K L Davis
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

5.  Effect of physostigmine on memory consolidation and retrieval processes in intact and nucleus basalis-lesioned rats.

Authors:  A C Santucci; P D Kanof; V Haroutunian
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  The selective 5-HT3 receptor antagonist, WAY100289, enhances spatial memory in rats with ibotenate lesions of the forebrain cholinergic projection system.

Authors:  H Hodges; P Sowinski; J D Sinden; C A Netto; A Fletcher
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

7.  Development of amygdaloid cholinergic mediation of passive avoidance learning in the rat. I. Muscarinic mechanisms.

Authors:  V Duméry; D Blozovski
Journal:  Exp Brain Res       Date:  1987       Impact factor: 1.972

8.  Therapeutic effect of THA on hemicholinium-3-induced learning impairment is independent of serotonergic and noradrenergic systems.

Authors:  J J Hagan; J H Jansen; F E Nefkens; T de Boer
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 9.  Diagnostic and pharmacological approaches in Alzheimer's disease.

Authors:  C Hermann; R G Stern; M F Losonzcy; S Jaff; M Davidson
Journal:  Drugs Aging       Date:  1991-03       Impact factor: 3.923

10.  Effects of iontophoretic administration of acetylcholine to rabbit motor cortex neurons on the functioning of intracortical connections.

Authors:  V N Khokhlova
Journal:  Neurosci Behav Physiol       Date:  1998 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.